LIU Huayi's Experience in Treatment of Precancerous Gastric Lesions with Weizhuan'an Granules(胃转安颗粒)

JIA Junbing; LIU Huayi

doi:10.13192/j.issn.1000-1719.2021.03.008

Suggestions

您当前的位置：

首页 >

文章列表页 >

LIU Huayi's Experience in Treatment of Precancerous Gastric Lesions with Weizhuan'an Granules(胃转安颗粒)

Previous: SHI Suofang's Experience on Treating Cough with Theory of Five Evolutive Phases and Six Climatic Changes

Next: 无

LIU Huayi's Experience in Treatment of Precancerous Gastric Lesions with Weizhuan'an Granules(胃转安颗粒)
1.Affiliated Hospital of Tianjin Traditional Chinese Medicine Research Institute, Tianjin 300120, China
DOI：10.13192/j.issn.1000-1719.2021.03.008

扫描看全文

JIA Junbing, LIU Huayi. LIU Huayi's Experience in Treatment of Precancerous Gastric Lesions with Weizhuan'an Granules(胃转安颗粒)[DB/OL].（2023-09-15）[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails#10.13192/j.issn.1000-1719.2021.03.008
DOI：

JIA Junbing, LIU Huayi. LIU Huayi's Experience in Treatment of Precancerous Gastric Lesions with Weizhuan'an Granules(胃转安颗粒)[DB/OL].（2023-09-15）[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails#10.13192/j.issn.1000-1719.2021.03.008 DOI：

摘要

胃癌是我国临床常见的肿瘤之一，胃癌前病变与胃癌密切相关，及早识别和治疗胃癌前病变向胃癌的进展，对开展胃癌的二级预防具有重要意义，刘华一主任治疗各种消化系统疾病方面经验丰富，对胃癌前病变治疗见解独特，刘师认为在各种致病因素下导致脾胃亏虚，以致瘀血、湿热、气滞等毒邪内生，损伤胃络，久而蕴积化热，血败肉腐，胃失濡养，发为本病，研究显示胃转安颗粒具有减轻异型增生，抑制端粒酶活性，抑制细胞增殖，具有阻断及逆转胃癌前期病变的作用。刘华一主任临床以胃转安颗粒为基础方，在其基础上辨证治疗，疗效突出，提高了患者生活质量及临床有效率，发挥了中医药在该领域的独特优势，值得在临床中的广泛推广。

Abstract

Gastric cancer is one of clinical common tumor in our country. The pathological changes before gastric carcinoma is closely related to gastric cancer, early diagnosis and treatment of gastric cancer before the disease to the progress of gastric cancer. It is of great significance for the secondary prevention of gastric cancer. Director LIU Huayi has rich experience on treating diseases of the digestive system. LIU argues a variety of pathogenic factors lead to the spleen and stomach deficiency, blood stasis, dampness-heat and Qi stagnation, damaging the stomach. Long-term damage could generate heat, blood loss and rotting flesh, resulting in this disease. The research has shown that Weizhuan'an Granule (胃转安颗粒) can relieve hyperplasia, inhibit telomerase activity and cell proliferation, and has the function of the block and reverse the stomach precancerous lesion. LIU Huayi takes Weizhuan'an Granule as the basic prescription. Based on its differentiation of symptoms and signs treatment, the curative effect is outstanding. It can improve patients' quality of life and clinical effectiveness and plays a unique advantages. It is worthy of popularizing widely in clinic.

关键词

胃癌前病变胃转安方中医药

Keywords

precancerous lesions of stomachWeizhuan'an Granule (胃转安颗粒)traditional Chinese medicine

references

中华医学会消化病分会. 中国慢性胃炎共识意见[J]. 胃肠病学, 2013(1): 24-36.

高金亮. 慢性萎缩性胃炎辨证示要[J]. 天津中医学院学报, 1992, 11(4): 12-13.

陈若冰, 袁慎俊, 刘丹, 等. 人参皂苷Rg3抗肿瘤作用机制的研究新进展[J]. 生命的化学, 2017, 37(4): 561-565.

杨娜, 周柏松, 王亚茹, 等. 人参皂苷Rg1生物活性研究进展[J]. 中华中医药杂志, 2018, 33(4): 1463-465.

邓晓霞, 李清宋, 陈中, 等. 黄芪抗肿瘤作用机制的研究进展[J]. 中药新药与临床药理, 2016, 27(3): 307-312.

向小庆, 叶红. 白术抗肿瘤作用的研究及应用进展[J]. 中国实验方剂学杂志, 2013, 19(8): 367-370.

王洲, 李茹柳, 徐颂芬, 等. 白术糖复合物对IEC-6细胞分化及绒毛蛋白表达的影响[J]. 中药材, 2010, 33(6): 938-944.

周云兰. 莪术油注射液治疗婴幼儿腹泻疗效观察[J]. 临床医学, 2009, 29(6): 89.

魏兰福, 邹百仓, 魏睦新, 等. 莪术对实验性功能性消化不良大鼠胃排空的影响[J]. 南京医科大学学报, 2003, 23(4): 352-450.

肖凯, 宣利江, 徐亚明, 等. 虎杖的化学成分研究[J]. 中国药学杂志, 2003, 38(1): 14-16.

曾红, 周秋贵, 罗婷, 等. 厚朴酚与和厚朴酚对小鼠腹泻及胃肠排空抑制的影响比较[J]. 中药材, 2015, 38(10): 2160-2162.

程弘夏, 李佩, 许腊英, 等. 厚朴及姜厚朴乙酸乙酯提取部位对小鼠胃肠运动功能的影响[J]. 中国实验方剂学杂志, 2014, 20(24): 141-143.

沈雅琴, 张明发. 半夏的镇痛、抗溃疡和抗血栓形成作用[J]. 中国生化药物杂志, 1998, 19(3): 141

赵惠仁, 胡书群, 任孝衡, 等. 红花素对晶体醋糖还原酶的抑制作用[J]. 中国药理学与毒理学杂志, 1993, 7(2): 159-160.

赫捷, 陈万青. 2012中国肿瘤登记年报[M]. 北京: 军事医学科学出版社, 2012:28.

江海涛, 刘华一, 张伯礼, 等. 胃转安方对胃癌前病变大鼠端粒酶活性的影响[J]. 江苏中医药, 2005, 26(6): 50-51.

刘华一, 王蓉, 王秀娟, 等. 胃转安方对胃癌前期病变大鼠端粒酶活性干预作用的实验研究[J]. 中医药学刊, 2004, 22(7): 1253-1254.

刘华一. 胃转安方对慢性萎缩性胃炎胃癌前病变的细胞凋亡通路影响机制研究[C]//中华中医药学会脾胃病分会第二十八届全国脾胃病学术交流会论文集, 2016.

杨阔, 刘华一, 王秀娟, 等. 胃转安方治疗胃癌前病变患者临床观察及胃蛋白酶原(PG)的影响[J]. 中华中医药学刊, 2016, 34(10): 2464-2467.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Syndrome Differentiation and Treatment of COVID-19 by Academician Tong Xiaolin:Origin, Innovation, and Development of "Cold-Dampness Plague" Theory

Experience on Discussion and Analysis on Application of Cancer Toxicology Theory

Identification and Treatment of Paroxysmal Atrial Fibrillation from Mutual Fanning of Liver Wind and Heart Fire

Seven Proved Cases of Mania

Professor ZHOU Caiyun's Clinical Experience in Stage Syndrome Differentiation Treatment of Behcet's Disease

Related Author

No data

Related Institution

Guang'anmen Hospital, China Academy of Chinese Medical Sciences

Beijing University of Chinese Medicine

The Third Affiliated Hospital of Zunyi Medical University

Northeast International Hospital

Human Phenome Institute, Fudan University

⁰